Search clinical trials for: remote ischemic conditioning (RIC)

Total 11558 results

East Carolina University

Recruiting

Effects of Remote Ischemic Conditioning on Bimanual Skill Learning and Corticospinal Excitability in Children With Unilateral Cerebral Palsy (RIC)

Unilateral Cerebral Palsy

United States
Peking University People's Hospital

Not yet recruiting

Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome

Myelodysplastic Syndromes | Acute Leukemia

China
Shanghai Jiao Tong University School of Medicine

Unknown

Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALL

Lymphoblastic Leukemia, Acute, Adult

China
Peking University People's Hospital

Recruiting

RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT

Myelodysplastic Syndromes | Acute Leukemia

China
Thomas J. Schnitzer
Novartis

Terminated

Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss

Bone Loss

United States
St. Olavs Hospital
Norwegian University of Science and Technology; Alesund Hospital

Active, not recruiting

Curative Image Guided Radiotherapy for Prostate Cancer (RIC)

Prostatic Neoplasms

Norway
University Hospital, Geneva

Not yet recruiting

Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC

Hematologic Malignancy | Haplo-identical Stem Cell Transplantation
Children's Hospital of Philadelphia

Recruiting

Fludarabine Based RIC for Bone Marrow Failure Syndromes

Bone Marrow Failure Syndromes

United States
First Affiliated Hospital of Zhejiang University
Second Affiliated Hospital, School of Medicine, Zhejiang University; Sir Run... and other collaborators

Recruiting

Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

Allogeneic Hematopoietic Stem Cell Transplantation | Hematologic Malignancy | Older Patients

China
Institut Paoli-Calmettes

Unknown

Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen (HaploMUD-RIC)

Multiple Myeloma | Non Hodgkin Lymphoma | Acute Leukemia

France
European Myeloma Network

Completed

Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation (EMN-alloRIC)

Multiple Myeloma | Hematologic Malignancies

Spain, Sweden, Germany, Italy
Northside Hospital, Inc.
Blood and Marrow Transplant Group of Georgia

Completed

Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant

Hematologic Neoplasms

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI); Massachusetts General Hospital; Brigham and...

Completed

Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma

Hodgkin Lymphoma | Non-hodgkin Lymphoma

United States
medac GmbH

Completed

Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

Germany, Italy, Poland, France, Finland, Hungary
Derek Yellon

Completed

Can RIC Prevent Deterioration to Critical Care in Covid19

Ischemia | Covid19

Brazil, South Africa, United Kingdom
Masonic Cancer Center, University of Minnesota

Recruiting

Allo HSCT Using RIC and PTCy for Hematological Diseases

Follicular Lymphoma | Myelodysplastic Syndromes | Leukemia, Myeloid | Myelofibrosis | Burkitt Lymphoma | Marginal Zone Lymphoma | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia | Plasma Cell Leukemia | Myeloproliferative Neoplasm | Small Lymphocytic... and other conditions

United States
Nantes University Hospital

Terminated

Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC (CYRIC)

Graft Versus Host Disease

France
Randy Windreich

Completed

Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS) | Hematopoietic Stem Cell Transplant (HSCT)

United States
Masonic Cancer Center, University of Minnesota

Recruiting

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

Hemoglobinopathies | Immunodeficiencies | Hematologic Disorders

United States
Peking University People's Hospital

Unknown

Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients

Leukemia | Myelodysplastic Syndrome

China
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis

Systemic Sclerosis

United States
Paul Szabolcs

Recruiting

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT (HSCT+RIC)

Congenital Bone Marrow Failure Syndromes | Inflammatory Conditions | Primary Immunodeficiency (PID) | Inherited Metabolic Disorders (IMD) | Hereditary Anemias | Systemic Juvenile Idiopathic Arthritis (sJIA)

United States
Wuhan Union Hospital, China

Recruiting

Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Allogeneic Hematopoietic Stem Cell Transplantation | Acute Myeloid Leukemia, Adult | Myelodysplastic Syndrome(MDS)

China
Federal University of Minas Gerais
Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de...

Completed

Preliminary Evidence of the Efficacy of a Mouthwash Containing 5% Propolis for the Control of Plaque and Gingivitis (MGP)

Gingivitis | Dental Plaque

Brazil
University of Birmingham

Active, not recruiting

A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC) (ALL-RIC)

Acute Lymphoblastic Leukemia

United Kingdom
Assistance Publique - Hôpitaux de Paris

Completed

Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT (ATG-CyGVHD)

Graft vs Host Disease

France
Running Injury Clinic
Alberta Health services; WCB Alberta

Unknown

An Efficacy Study of Exercise Rehabilitation on Pain and Disability for Patients With Non-specific Low Back Pain (LBP-RCT)

Low Back Pain, Mechanical

Canada
Sonova AG
Sonova Canada Inc.

Completed

Clinical Study of Released Unitron RIC and BTE Hearing Aid Models

Hearing Loss

Canada
Washington University School of Medicine

Recruiting

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Hemoglobinopathies | Bone Marrow Failure Syndromes | Metabolic Disorders | Non-malignant Disorders | Severe Sickle Cell Disease | Immunologic Disorders

United States
University Hospital, Montpellier
Carémeau University Hospital, Nîmes

Completed

Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease (RIC-1)

Crohn's Disease

France
CellAegis US, Inc.

Unknown

Remote Ischemic Conditioning Using the autoRIC (SHIELD)

Ischemia-Reperfusion Injury

Canada, United States
Nantes University Hospital

Completed

Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL) (Cloric)

AML | MDS | ALL | BAL

France
Hasselt University

Recruiting

Rhythmic Interlimb Coordination in Children With Developmental Coordination Disorder

Developmental Coordination Disorder

Belgium
University of Calgary
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Alberta Heritage... and other collaborators

Completed

Exercise Intervention and Running Biomechanics in Older Adults

Physical Activity | Aging

Canada
Seth Gordhandas Sunderdas Medical College

Completed

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

Cushing's Disease | Corticotroph Adenoma

India
Holdsworth House Medical Practice
Gilead Sciences

Completed

Patient Retention in HIV Medical Care in a Primary Care Practice in Australia (RiC)

HIV

Australia
Al-Azhar University

Completed

Evaluation of the Remineralizing and Antibacterial Effect of Natural Versus Synthetic Materials on Deep Carious Dentin

Dentin Caries

Egypt
Masonic Cancer Center, University of Minnesota

Terminated

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases

Sickle Cell Disease | Thalassemia | Cerebral Adrenoleukodystrophy | Inherited Metabolic Disorders | High Risk Hematologic Disorders

United States
Nantes University Hospital

Recruiting

Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT (FLUCLORIC)

Acute Myeloid Leukemia in Remission

France
Columbia University

Terminated

Reduced Intensity AlloSCT in(CML) With Persistent Disease (CML)

Chronic Myeloid Leukemia

United States
Institute of Tropical Medicine, Belgium
University of Gondar; Boru Meda Hospital

Completed

Outcomes of Complicated CL in Ethiopia Treated With Miltefosine

Cutaneous Leishmaniases

Ethiopia
University Hospital, Bordeaux
Bayer

Completed

Safety of Ibritumomab Tiuxetan (Zevalin®) in Combination With a Fludarabine-based Reduced Intensity Conditioning (RIC) Regimen (ZEVALLO 2007) (ZEVALLO)

Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma

France
IBSA Institut Biochimique SA

Completed

Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.

Infertility

France, Hungary
University of Bologna

Completed

Nutritional Trial With Probiotic Fortified Milk in Women Affected by Insomnia (Prosit)

Sleep Disorders

Italy
Istituto Clinico Humanitas

Unknown

Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis Lymphomas

Lymphoma

Italy
Dana-Farber Cancer Institute
Wyeth is now a wholly owned subsidiary of Pfizer; PDL BioPharma, Inc.

Terminated

Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation

Graft-vs-Host Disease

United States
Ruhr University of Bochum

Completed

Examination of the Pathophysiologic Mechanisms of CRPS by Using QST, CPM, RIC, and Heart Rate Variability QST

Neuralgia | Carpal Tunnel Syndrome | Complex Regional Pain Syndrome

Germany
Pfizer

Completed

A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS

Restless Legs Syndrome

Austria, Germany, Switzerland, Sweden
Drugs for Neglected Diseases
London School of Hygiene and Tropical Medicine; Institute of Tropical Medicine... and other collaborators

Completed

Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.

Visceral Leishmaniasis

Ethiopia
Hopital Nord Franche-Comte

Completed

Vaccination Against SARS-Cov2 (COVID-19) in Chronic Inflammatory Rheumatism and Factors Determining Its Decision. (VACCI-RIC)

Rheumatoid Arthritis | Spondyloarthritis

France

Search clinical trials for: remote ischemic conditioning (RIC)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations